Add to ORKGPh. D. University of Durban-Westville 1998.No abstract available.A summary with literature review is available
Tuberculosis is an ancient infectious disease and a leading cause of death globally. Preclinical res...
Philosophiae Doctor - PhDBackground: Tuberculosis (TB) is a major cause of morbidity and mortality a...
The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-...
Includes bibliographical references (leaves 190-203).A prospectlve pharmacokinetic study was conduct...
This pharmacokinetic sub-study was nested within the phase-III OFLOTUB study investigating the short...
Includes abstract.Includes bibliographical references.The pharmacokinetics of rifampicin, isoniazid,...
The aim of this study was to compare the pharmacokinetics of antituberculosis drugs in patients with...
With approximately 3 million annual deaths in the 1990’s, tuberculosis remains a leading cause of mo...
The low permeability of the cell envelope against hydrophilic anti-tuberculosis (TB) drugs especiall...
Background. Early mortality among hospitalized HIV-associated tuberculosis (TB/HIV) patients is high...
Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2008.With the rise of t...
With 10 million new infections yearly, tuberculosis has a major impact on the human well-being of th...
by Walubo Andrew.Thesis (M.Phil.)--Chinese University of Hong Kong, 1991.Bibliography: leaves 148-17...
OBJECTIVE: To assess the pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyraz...
Every year over one million people die from tuberculosis. People infected with HIV are significantly...
Tuberculosis is an ancient infectious disease and a leading cause of death globally. Preclinical res...
Philosophiae Doctor - PhDBackground: Tuberculosis (TB) is a major cause of morbidity and mortality a...
The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-...
Includes bibliographical references (leaves 190-203).A prospectlve pharmacokinetic study was conduct...
This pharmacokinetic sub-study was nested within the phase-III OFLOTUB study investigating the short...
Includes abstract.Includes bibliographical references.The pharmacokinetics of rifampicin, isoniazid,...
The aim of this study was to compare the pharmacokinetics of antituberculosis drugs in patients with...
With approximately 3 million annual deaths in the 1990’s, tuberculosis remains a leading cause of mo...
The low permeability of the cell envelope against hydrophilic anti-tuberculosis (TB) drugs especiall...
Background. Early mortality among hospitalized HIV-associated tuberculosis (TB/HIV) patients is high...
Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2008.With the rise of t...
With 10 million new infections yearly, tuberculosis has a major impact on the human well-being of th...
by Walubo Andrew.Thesis (M.Phil.)--Chinese University of Hong Kong, 1991.Bibliography: leaves 148-17...
OBJECTIVE: To assess the pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyraz...
Every year over one million people die from tuberculosis. People infected with HIV are significantly...
Tuberculosis is an ancient infectious disease and a leading cause of death globally. Preclinical res...
Philosophiae Doctor - PhDBackground: Tuberculosis (TB) is a major cause of morbidity and mortality a...
The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-...